Form 4: Tenet Healthcare Director Richard Fisher Reports Stock Transactions, Including RSU Settlement and Share Sale

Tenet Healthcare Corp. Director Richard W. Fisher reported the settlement of restricted stock units, the sale of common stock, and the grant of new restricted stock units.

Summary

• Richard W. Fisher, a Director at Tenet Healthcare Corp (THC), engaged in multiple equity transactions on May 22 and May 23, 2025.
• On May 23, 2025, Mr. Fisher settled 1,551 Restricted Stock Units (RSUs), receiving 63% in shares of THC common stock and 37% in cash.
• Following the RSU settlement, he acquired 1,551 shares of common stock.
• Subsequently, on May 23, 2025, Mr. Fisher disposed of 573 shares of THC common stock at a price of $161.33 per share.
• On May 22, 2025, he was granted 1,333 new Restricted Stock Units under the Company's Stock Incentive Plan.
• Each RSU is the economic equivalent of one share of common stock, and the newly granted RSUs are set to vest on May 22, 2026.
• After these reported transactions, Mr. Fisher's direct beneficial ownership of common stock stands at 15,205 shares, down from 15,778 shares prior to the sale.
• His direct beneficial ownership of Restricted Stock Units is 1,333 units.

Sentiment

Score: 5

Explanation: The document is a standard Form 4 filing detailing insider transactions. It presents routine equity compensation activities (RSU settlement, new grant) and a minor share sale, which are neutral in nature and do not inherently indicate positive or negative company performance or outlook.

Positives

• The grant of 1,333 new Restricted Stock Units to Director Richard W. Fisher indicates continued alignment of management incentives with shareholder interests, as these units vest over time.

Negatives

• Director Richard W. Fisher sold 573 shares of common stock at $161.33 per share, which could be perceived as a slight reduction in direct equity exposure by an insider.

Future Outlook

The newly granted 1,333 Restricted Stock Units to Director Richard W. Fisher are scheduled to vest on May 22, 2026, which is the first anniversary of their grant date.

Management Comments

• Each restricted stock unit was the economic equivalent of one share of Tenet Healthcare Corp (THC) common stock.
• The reporting person settled 37% of his restricted stock units for cash and 63% for shares of THC common stock.
• The newly granted restricted stock units vest on the first anniversary of the date of grant, and the reporting person may elect to receive up to 37% of these restricted stock units in cash in lieu of shares.

Industry Context

This Form 4 filing details routine insider transactions related to equity compensation, which is a common practice across all industries for aligning executive and director interests with company performance. The specific transactions reflect a director managing their equity holdings, including the settlement of previously granted restricted stock units and the receipt of new ones, alongside a partial sale of common stock.

Stakeholder Impact

• Shareholders: The sale of 573 shares by a director represents a minor reduction in insider ownership, while the new RSU grant reinforces long-term alignment. The overall impact on shareholder confidence from these routine transactions is likely minimal.

Next Steps

• The 1,333 Restricted Stock Units granted on May 22, 2025, are expected to vest on May 22, 2026.

Key Dates

Keywords

Tenet Healthcare, THC, Form 4, Insider Trading, Director Stock Sale, Restricted Stock Units, RSU, Stock Incentive Plan, Richard W. Fisher